New York Times Insider Sold Shares Worth $1,003,897, According to a Recent SEC Filing-March 2024-www.financetom.com

New York Times Insider Sold Shares Worth $1,003,897, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

New York Times Insider Sold Shares Worth $1,003,897, According to a Recent SEC Filing

Feb 18, 2025 3:20 PM

05:50 PM EST, 02/18/2025 (MT Newswires) -- Meredith A. Kopit Levien, Director, President & CEO, on February 13, 2025, sold 19,869 shares in New York Times ( NYT ) for $1,003,897. Following the Form 4 filing with the SEC, Levien has control over a total of 81,903 shares of the company, with 81,903 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/71691/000007169125000023/xslF345X05/wk-form4_1739918539.xml

Previous page： Japan's union group Rengo announces biggest wage hikes on record Next page： Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Japan's union group Rengo announces biggest wage hikes on record

Mar 22, 2024

TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...

Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug

Mar 22, 2024

05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...

Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut

Mar 22, 2024

Kevin O'Leary Wants To Buy TikTok And Is Scouting For Investment: 'An Interesting Deal And I Like It'

Mar 22, 2024

Amidst talks of a potential TikTok ban, Kevin O’Leary of “Shark Tank” fame expressed interest in purchasing the Chinese-owned app on Thursday. What happened: O’Leary revealed that several groups are forming to bid for TikTok, and he’s among those interested. He emphasized his recognizable brand and vision to transition TikTok into an American-owned platform. “And you have to be a steward to change it from TikTok China...